Multi-omic Evaluation of the mTOR pathway in Radiotherapy-Related Fatigue
Multi-omic Evaluation of the mTOR pathway in Radiotherapy-Related Fatigue
批准号:
10665092
负责人:
Velda Janet Gonzalez-Mercado
金额:
$16.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2024-07-31
关键词:
70-kDa Ribosomal Protein S6 KinasesAcuteAddressAreaBioinformaticsBiologicalBiological AssayBiological ProcessBlood specimenCancer PatientCandidate Disease GeneClinical DataCollaborationsComplexDNA MethylationDNA methylation profilingDataDevelopmentDistressEnzyme-Linked Immunosorbent AssayEtiologyEvaluationEventExpenditureFRAP1 geneFatigueGene ExpressionGenesGeneticGenetic MarkersGenomicsGoalsGrantHomeostasisIncidenceInflammationInterventionJournalsKnowledgeLiteratureMalignant NeoplasmsMalignant neoplasm of prostateMentorsMentorshipMethodsMitochondriaModelingMolecularMolecular TargetOxidative StressPathway interactionsPatientsPeer ReviewPerformancePhenotypePhosphorylationPlasmaPopulationPostdoctoral FellowProductivityProstate Cancer therapyProteinsProto-Oncogene Proteins c-aktPublicationsRadiation therapyRegimenReportingResearchResearch PersonnelResearch ProposalsSamplingScienceScientistSeriesSirolimusStrategic PlanningSymptomsSystemTSC1 geneTSC1/2 geneTrainingUnited States National Institutes of HealthWhole BloodWorkWritingadenylate kinasebiobehaviorcancer therapycare episodecareercell growthclinically significantdesigndifferential expressiondisabling symptomeconomic implicationeffective interventioneffective therapyenergy balanceepigenetic markerepigenetic regulationepigenomicsexperienceimprovedinnovationlaboratory experiencemTOR Signaling Pathwaymenmitochondrial dysfunctionmortalitymultiple omicsnovelpatient oriented researchpersonalized medicinepreventprognosticprostate radiotherapyprotein expressionradiation responseside effectskillssymptom managementsymptom sciencetherapeutic targettranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Cancer-related fatigue is one of the most debilitating, distressing, and commonly reported side effects of cancer
treatment, with up to 71% of prostate cancer (PC) patients complaining of fatigue during radiation therapy (RT).
While the etiology and associated mechanisms of the fatigue responses to RT treatment remain elusive, the
candidate recently found evidence that changes in gene expression of both MTOR and p70S6K were associated
with changes in fatigue during RT. The proposed study will explore the network of interactions among the
biomolecules present in mTOR signaling pathways at the systems level, which could shift existing symptom
management paradigm as it relates to fatigue by offering an understanding of how the mTOR biological functions
are regulated and how the fatigue may emerge from its dysregulation. The proposed research is guided by a
model of dysregulation of the mTOR pathway and RT-related fatigue. The training plan was designed to allow
the candidate to build on her post-doctoral experience to receive the necessary training to become an
independent investigator, proficient in genomics, other “omics”, and bioinformatics as they relate to symptom
science. An experienced team of scientists will provide career mentoring and training with the following
objectives: (1) enhance knowledge of “omics” (i.e., transcriptomics, epigenomics), and the science related to
mechanisms of symptoms; (2) gain additional expertise in the characterization of fatigue phenotypes and in
relation to patient biological and clinical data; (3) attain bioinformatics proficiency (via didactic coursework and
comprehensive hands-on training) in the analysis of transcriptomic, epigenomic, and protein data, and
interpretation of the findings; and (4) improve scientific writing skills and build collaborations with experts in the
fields of bio-behavioral, symptom management, and omic research that will allow for successful publications in
high-impact, peer-reviewed journals, and submission of competitive NIH R-Series grant. The training plan is for
thirty-six months and includes six core areas: didactic; interdisciplinary seminars; mentorship; laboratory training;
research; and dissemination. There are 3 specific aims proposed. Aim 1: Identify mTOR pathway and activity-
related genes associated with changes in fatigue scores from pre, end, and 1 month after stereotactic body
radiation therapy (SBRT) in a sample of men with PC. Aim 2: Investigate the relationships between epigenetic
regulation of mTOR pathway genes associated with changes in fatigue scores from pre, end, and 1 month after
SBRT in a sample of men with PC. Aim 3: Determine the associations between changes in mTOR signaling
pathway and activity-related proteins with changes in fatigue scores from pre, end, and 1 month after SBRT in a
sample of men with PC. This study identifies a novel area for exploration and aligns well with the NINR Strategic
Plan calling for studies on symptom science with a focus on Promoting Personalized Medicine, by understanding
the mechanisms underlying the symptom of fatigue through symptom science research.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1155/2021/7967552
发表时间:
2021
期刊:
Depression research and treatment
影响因子:
--
作者:
[Gonzalez-Mercado VJ, Lim J, Saligan LN, Perez N, Rodriguez C, Bernabe R, Ozorio S, Pedro E, Sepehri F, Aouizerat B]
通讯作者:
Aouizerat B
Multi-omic Evaluation of the mTOR pathway in Radiotherapy-Related Fatigue
-
批准号:10487526
-
项目类别:
-
资助金额:$16.71万
-
财政年份:2021
-
负责人:Velda Janet Gonzalez-Mercado
-
依托单位:
Multi-omic Evaluation of the mTOR pathway in Radiotherapy-Related Fatigue
-
批准号:10282354
-
项目类别:
-
资助金额:$16.71万
-
财政年份:2021
-
负责人:Velda Janet Gonzalez-Mercado
-
依托单位:
Fatigue and the Gut Microbiome of Patients Receiving Chemoradiotherapy for Rectal Cancer
-
批准号:9327348
-
项目类别:
-
资助金额:$5.9万
-
财政年份:2017
-
负责人:Velda Janet Gonzalez-Mercado
-
依托单位:
海外基金